Cutaneous Invasive Fungal Infections with Saksenaea Species in Immunocompetent Patients in Europe: A Systematic

Andrea Planegger1, Semra Uyulmaz1, Audrius Poskevicius2

  • 1Department of Plastic Surgery and Hand Surgery, University Hospital Zurich, Zurich, Switzerland.

Insights

Invasive fungal infections caused by Saksenaea are rare in Europe. Early diagnosis and treatment of these mucormycosis infections are crucial for a good prognosis in immunocompetent patients.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Dermatology

Background:

  • Invasive fungal infections caused by Saksenaea species, a type of mucormycosis, are infrequently reported in central European climates.
  • Cutaneous infections with Saksenaea are particularly rare, with limited data available on their presentation and management in immunocompetent individuals.

Purpose of the Study:

  • To enhance awareness of invasive cutaneous Saksenaea infections.
  • To systematically review and analyze European cases of Saksenaea infections in immunocompetent hosts.
  • To summarize epidemiology, clinical presentation, diagnosis, and management strategies.

Main Methods:

  • Systematic review adhering to Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines.
  • Identification and analysis of all reported European cases of Saksenaea infection in immunocompetent individuals.
  • Summarization of epidemiological, clinical, microbiological, and management data.

Main Results:

  • The study identified the first case of invasive cutaneous Saksenaea infection in an immunocompetent 79-year-old patient in Switzerland.
  • The infection, originating from minor skin trauma, led to fulminant necrosis and significant tissue loss.
  • Combined surgical debridement and antifungal therapy, followed by muscle flap reconstruction, successfully managed the infection over 63 days.

Conclusions:

  • Early diagnosis and prompt, appropriate antifungal and surgical treatment are critical for favorable outcomes in Saksenaea soft tissue infections.
  • Successful tissue reconstruction is achievable even with ongoing antifungal therapy.